chimeric antigen receptor T-cell therapy

Chimeric Antigen Receptor (CAR) T-cell therapy is an advanced treatment that uses a patient’s own immune cells, called T-cells, modified in a lab to better recognize and attack cancer cells. Scientists engineer these T-cells to express a special receptor (CAR) that binds to specific proteins on cancer cells. Once infused back into the patient’s body, these customized T-cells seek out and destroy cancer cells, often leading to significant tumor reduction. This personalized approach harnesses and enhances the body's immune response, providing a targeted and potent option for certain types of blood cancers.